17 alpha-hydroxyprogesterone caproate has been researched along with Cancer of Endometrium in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 8 (50.00) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huo, Z; Lang, JH; Shen, K; Wu, M; Yang, JX; Yu, M | 1 |
| Brockbank, E; Bryant, A; Gallagher, C; Kokka, F; Oram, D | 1 |
| BAGINSKY, S; KISTNER, RW | 1 |
| Izutsu, T; Sugiyama, T | 1 |
| Aoki, D; Banno, K; Nozawa, S; Susumu, N; Suzuki, A; Suzuki, N; Tamada, Y | 1 |
| Yang, D; Zhu, RL | 1 |
| Dyba, T; Karolewski, K; Klimek, M; Kojs, Z; Urbański, K | 1 |
| Chepick, OF | 1 |
| Charkviani, TL | 1 |
| Loutfi, G; Vishnevsky, AS | 1 |
| Liu, XS; Zhang, X | 1 |
| Bokhman, IV; Chepik, OF; Ermakova, NA; Maksimov, SI; Mikaia, NA; Nezhentseva, EL; Tsyrlina, EV; Vishnevskiĭ, AS | 1 |
| Cao, B; Zhang, X | 1 |
| Jarvis, G; Kitchener, H; Lilford, R; Martin-Hirsch P, L | 1 |
| Adamian, RT | 1 |
| Rozdolski, K | 1 |
4 review(s) available for 17 alpha-hydroxyprogesterone caproate and Cancer of Endometrium
| Article | Year |
|---|---|
Hormonal therapy in advanced or recurrent endometrial cancer.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Antineoplastic Agents, Hormonal; Disease-Free Survival; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone Acetate; Megestrol; Neoplasm Recurrence, Local; Neoplasm Staging; Progestins | 2010 |
[Hormone therapy for uterine corpus cancer--introduction].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Hydroxyprogesterones; Leuprolide; Medroxyprogesterone Acetate; Raloxifene Hydrochloride; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome | 2004 |
[Conservative hormonal therapy for endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasm Staging; Treatment Outcome | 2004 |
Progestagens for endometrial cancer.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone Acetate; Progestins | 2000 |
6 trial(s) available for 17 alpha-hydroxyprogesterone caproate and Cancer of Endometrium
| Article | Year |
|---|---|
Adjuvant progestagen therapy improves survival in patients with endometrial cancer after hysterectomy. Results of one-institutional prospective clinical trial.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Actuarial Analysis; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Hysterectomy; Middle Aged; Neoplasm Invasiveness; Prognosis; Proportional Hazards Models; Prospective Studies; Radioisotope Teletherapy; Survival Rate; Treatment Outcome | 1993 |
Morphological aspects of the hormone-induced pathomorphosis of endometrial carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Antineoplastic Agents; Cell Division; Chemotherapy, Adjuvant; Clomiphene; Contraceptives, Oral, Hormonal; Endometrial Neoplasms; Enzymes; Estradiol; Female; Glycogen; Humans; Hydroxyprogesterones; Microscopy, Electron; Neoplasm Staging; Neoplasms, Hormone-Dependent; Remission Induction | 1993 |
Favourable influence of adjuvant hormone therapy by oxyprogesterone caproate (OPC) and by its combination with tamoxifen on 5-year survival rate of surgical and combined treatment of primary endometrial carcinoma patients.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Hysterectomy; Middle Aged; Neoplasms, Hormone-Dependent; Prospective Studies; Survival Rate; Tamoxifen | 1993 |
[Comparison between the roles of aminoglutethimide and hydroxyprogesterone caproates in the treatment of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Double-Blind Method; Endometrial Neoplasms; Estradiol; Female; Humans; Hydroxyprogesterones; Middle Aged; Progesterone | 1995 |
Exploration for drug therapy in endometrial carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinoma, Squamous Cell; Double-Blind Method; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Middle Aged; Tamoxifen | 1996 |
[Therapy of atypical hyperplasia and adenocarcinoma of the endometrium with the combination of progestins and anticoagulants].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Anticoagulants; Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Endometrial Neoplasms; Endometrium; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Hyperplasia; Medroxyprogesterone Acetate; Neoplasm Staging; Progesterone Congeners; Treatment Outcome | 2001 |
6 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Cancer of Endometrium
| Article | Year |
|---|---|
Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Antineoplastic Agents, Hormonal; Cell Differentiation; Combined Modality Therapy; Endometrial Neoplasms; Endometrium; Female; Fertility; Follow-Up Studies; Humans; Hydroxyprogesterones; Hyperplasia; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Progestins; Remission Induction; Reproductive Techniques, Assisted; Retrospective Studies; Severity of Illness Index | 2009 |
Observations on the use of 17-alpha-hydroxy-progesterone caproate on primary metastatic endometrial carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Progesterone; Uterine Neoplasms | 1961 |
[Changes in reproductive hormones levels in the treatment of endometrial precancerous lesion with hydroxyprogesterone caproate].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Antineoplastic Agents; Delayed-Action Preparations; Endometrial Neoplasms; Female; Follicle Stimulating Hormone; Humans; Hydroxyprogesterones; Luteinizing Hormone; Middle Aged; Precancerous Conditions; Progesterone Congeners | 1994 |
Optimal variants of treatment of stage I endometrial carcinoma and its choice.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasms, Hormone-Dependent; Prospective Studies; Retrospective Studies; Survival Rate; Treatment Outcome | 1993 |
[Parameters of estrogen expression in patients with endometrial tumors as prognostic signs of the effectiveness of neoadjuvant antitumor hormone therapy].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Aged; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Endometrial Neoplasms; Estrogen Antagonists; Estrogens; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroxyprogesterones; Middle Aged; Postmenopause; Prognosis; Tamoxifen | 1996 |
[The effect of progestins on endometrial cancer in morphometric evaluation].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Hysterectomy; Interphase; Middle Aged; Stromal Cells; Time Factors; Tumor Cells, Cultured | 2001 |